Which are the causes of Factor XIII Deficiency?

Factor XIII Deficiency is primarily caused by mutations in the F13A1 or F13B genes, which prevent the body from producing the necessary protein to stabilize blood clots. While most cases are inherited through an autosomal recessive pattern, acquired forms can also develop due to autoimmune responses or underlying health conditions.

What are the genetic causes of Factor XIII Deficiency?

In its congenital form, Factor XIII Deficiency is a rare, inherited bleeding disorder. It occurs when an individual inherits two mutated copies of the genes responsible for creating the Factor XIII protein—a "glue" that holds blood clots together. The F13A1 gene provides instructions for the A-subunit, while the F13B gene codes for the B-subunit. If these genes do not function correctly, the clot remains fragile and can break down prematurely, leading to prolonged bleeding.

Can Factor XIII Deficiency be acquired?

Yes, Factor XIII Deficiency can also be acquired later in life, meaning it is not always present from birth. This secondary form is typically caused by mechanisms that interfere with the body's ability to produce or maintain the protein, including:

• Autoimmune reactions: The body’s immune system mistakenly produces antibodies that attack and neutralize Factor XIII.


• Liver disease: Since the liver produces many clotting factors, severe liver dysfunction can reduce levels of the protein.


• Medications or underlying malignancy: Certain drugs or cancers can inhibit the production or accelerate the clearance of Factor XIII.

Is the cause of Factor XIII Deficiency fully understood?

While the genetic basis for congenital Factor XIII Deficiency is well-mapped, researchers are still investigating the precise triggers for acquired cases. It is important to distinguish between the cause—the direct biological origin of the low protein levels—and risk factors, which are external circumstances (like drug exposure or autoimmune history) that increase the likelihood of developing the acquired form. Current research at institutions globally is focused on identifying novel genetic variants and developing more targeted therapies to restore Factor XIII levels in patients.

Next steps

• Consult a hematologist for specialized coagulation testing and genetic counseling.


• Connect with others at DiseaseMaps.org to share experiences with this rare condition.


• Monitor for warning signs like unexplained bruising or prolonged wound bleeding.


• Discuss potential clinical trials or registry participation with your medical team.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Factor XIII Deficiency overview.


• Orphanet: Rare disease portal for congenital Factor XIII deficiency.


• Online Mendelian Inheritance in Man (OMIM): F13A1 and F13B gene entries.


• World Federation of Hemophilia (WFH): Clinical guidelines for rare bleeding disorders.